Skip to content

Clinical trials

Terminated Carcinoma, Non-Small-Cell Lung trials in Hong Kong

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Status: Terminated Country / region: Hong Kong Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20053
20061
20071
20082
20092
20121
20143
20171
20182
20193
20201
20212

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated22

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals7
Pfizer3
Clovis Oncology, Inc.2
Merck Sharp & Dohme LLC2
AVEO Pharmaceuticals, Inc.1
Amgen1
Bayer1
GlaxoSmithKline1
Merck KGaA, Darmstadt, Germany1
NRG Oncology1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung22
Lung Neoplasms4
Neoplasm Metastasis4
Neoplasms4
Recurrence3
Colorectal Neoplasms2
Adenocarcinoma of Lung1
Anemia1
Brain Neoplasms1
Breast Neoplasms1

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.